NHS National Generics Pharmaceuticals - Supply Chain Resilience

Award outcome

Framework agreement

Description

NHS National Generics Pharmaceuticals - Supply Chain Resilience Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Periods of call-offs under the framework agreement: CM/PHG/25/5739/01 – Orals (plus non-parenteral) Products CESW: (Midlands and Southwest): 1st September 2026 to 31st May 2028 (21 months) NWLN: (Northwest and London North): 1st September 2026 to 31st May 2028 (21 months) LSNE: (London South and Northeast): 1st September 2026 to 31st May 2028 (21 months) CM/PHG/25/5739/02 – Hospital Only Products DLS (London South) & DNE (North-East): 1st September 2026 to 31st May 2028 (21 months) DLN (London North) & DNW (North-West): 1st September 2026 to 31st May 2028 (21 months) DCE (Central/Midlands) & DSW (South-West): 1st September 2026 to 30th September 2027 (13 months)

Links & Documents

About NHS England

Published contracts in the last 12 months

Similar contracts